Brief: Idera Pharmaceuticals Reports Q3 Loss Per Share Of $0.43

Aceragen

06/11/2018 22:11

Nov 6 (Reuters) - Idera Pharmaceuticals Inc  IDRA.O :
    * IDERA PHARMACEUTICALS REPORTS THIRD QUARTER 2018 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * Q3 LOSS PER SHARE $0.43
    * Q3 EARNINGS PER SHARE VIEW $-0.58 -- THOMSON REUTERS
I/B/E/S
    * TO PROVIDE ILLUMINATE 204 DATA UPDATE IN FIRST HALF OF
DECEMBER
2018
    * AS OF SEPT 30, 2018, CO'S CASH AND CASH EQUIVALENTS
TOTALED
$82.5 MILLION
    * IDERA PHARMACEUTICALS-ANTICIPATES BASED ON CURRENT
OPERATING
PLAN, EXISTING CASH, CASH EQUIVALENTS WILL BE SUFFICIENT TO FUND
OPERATIONS INTO Q1 2020

Source text for Eikon:  ID:nGNX8TZF4z 
Further company coverage:  IDRA.O 

 (Reuters.Briefs@thomsonreuters.com)